Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis
Latest Information Update: 02 Feb 2024
At a glance
- Drugs Filgotinib (Primary) ; Adalimumab
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- Acronyms JAKAR
Most Recent Events
- 31 Jan 2024 Status changed from not yet recruiting to discontinued.
- 19 Aug 2022 New trial record